BRPI0815460A2 - kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos - Google Patents
kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferosInfo
- Publication number
- BRPI0815460A2 BRPI0815460A2 BRPI0815460A BRPI0815460A BRPI0815460A2 BR PI0815460 A2 BRPI0815460 A2 BR PI0815460A2 BR PI0815460 A BRPI0815460 A BR PI0815460A BR PI0815460 A BRPI0815460 A BR PI0815460A BR PI0815460 A2 BRPI0815460 A2 BR PI0815460A2
- Authority
- BR
- Brazil
- Prior art keywords
- diagnostic kit
- mammalian subjects
- predicting cancer
- genes
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos". a presente invenção respeita a um conjunto de genes ou 5 proteínas consistindo em ou compreendendo pelo menos, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 10 possivelmente 100, 105, 110 genes ou proteínas ou o conjunto completo seleccionado a partir do quadro 10 e/ou do quadro 11 ou anticorpos (ou a porção hipervariável dos mesmos) dirigidos contra as proteínas codificadas por tais genes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97074307P | 2007-09-07 | 2007-09-07 | |
PCT/EP2008/061828 WO2009030770A2 (en) | 2007-09-07 | 2008-09-05 | Methods and tools for prognosis of cancer in er- patients |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0815460A2 true BRPI0815460A2 (pt) | 2019-02-26 |
Family
ID=40076838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0815460A BRPI0815460A2 (pt) | 2007-09-07 | 2008-09-05 | kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos |
Country Status (7)
Country | Link |
---|---|
US (1) | US20100298160A1 (pt) |
EP (1) | EP2185728A2 (pt) |
JP (1) | JP2010537659A (pt) |
AU (1) | AU2008294687A1 (pt) |
BR (1) | BRPI0815460A2 (pt) |
CA (1) | CA2696947A1 (pt) |
WO (1) | WO2009030770A2 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080275652A1 (en) * | 2005-05-13 | 2008-11-06 | Universite Libre De Bruxelles | Gene-based algorithmic cancer prognosis |
WO2010118782A1 (en) | 2009-04-17 | 2010-10-21 | Universite Libre De Bruxelles | Methods and tools for predicting the efficiency of anthracyclines in cancer |
EP2270510A1 (en) * | 2009-07-02 | 2011-01-05 | EMBL (European Molecular Biology Laboratory) | Diagnostic method for predicting the risk of cancer recurrence based on Histone macroH2A isoforms |
WO2012078648A2 (en) * | 2010-12-06 | 2012-06-14 | University Of Medicine And Dentistry Of New Jersey | Novel method of cancer diagnosis and prognosis and prediction of response to therapy |
WO2015117204A1 (en) * | 2014-02-06 | 2015-08-13 | Immunexpress Pty Ltd | Biomarker signature method, and apparatus and kits therefor |
JP7304030B2 (ja) * | 2019-04-26 | 2023-07-06 | 国立大学法人 東京大学 | がん治療の効果および予後の予測方法および治療手段の選択方法 |
DE102020203224A1 (de) | 2020-03-12 | 2021-09-16 | Heinrich-Heine-Universität Düsseldorf | Inhibition von FKBP1A zur Therapie des Triple-negativen Mammakarzinoms |
EP4118431A1 (de) | 2020-03-12 | 2023-01-18 | Heinrich-Heine-Universität Düsseldorf | Inhibition von fkbp1a zur therapie des triple-negativen mammakarzinoms |
CN113025716A (zh) * | 2021-03-02 | 2021-06-25 | 北京大学第一医院 | 一种用于人肿瘤分级的基因组合及其用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0323225D0 (en) * | 2003-10-03 | 2003-11-05 | Ncc Technology Ventures Pte Lt | Materials and methods relating to breast cancer classification |
EP1800130B1 (en) * | 2004-09-22 | 2011-08-17 | Tripath Imaging, Inc. | Methods and compositions for evaluating breast cancer prognosis |
AU2006246241A1 (en) | 2005-05-13 | 2006-11-16 | Universite Libre De Bruxelles | Gene-based algorithmic cancer prognosis |
US20080275652A1 (en) * | 2005-05-13 | 2008-11-06 | Universite Libre De Bruxelles | Gene-based algorithmic cancer prognosis |
US20070218512A1 (en) * | 2006-02-28 | 2007-09-20 | Alex Strongin | Methods related to mmp26 status as a diagnostic and prognostic tool in cancer management |
-
2008
- 2008-09-05 EP EP08803797A patent/EP2185728A2/en not_active Withdrawn
- 2008-09-05 WO PCT/EP2008/061828 patent/WO2009030770A2/en active Application Filing
- 2008-09-05 AU AU2008294687A patent/AU2008294687A1/en not_active Abandoned
- 2008-09-05 US US12/733,574 patent/US20100298160A1/en not_active Abandoned
- 2008-09-05 JP JP2010523521A patent/JP2010537659A/ja active Pending
- 2008-09-05 CA CA2696947A patent/CA2696947A1/en not_active Abandoned
- 2008-09-05 BR BRPI0815460A patent/BRPI0815460A2/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2010537659A (ja) | 2010-12-09 |
US20100298160A1 (en) | 2010-11-25 |
CA2696947A1 (en) | 2009-03-12 |
WO2009030770A3 (en) | 2009-05-07 |
EP2185728A2 (en) | 2010-05-19 |
AU2008294687A1 (en) | 2009-03-12 |
WO2009030770A2 (en) | 2009-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0815460A2 (pt) | kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos | |
DK1874818T3 (da) | TGF-Beta 1-specifikke antistoffer | |
PH12016500658A1 (en) | Human anti-alpha-synuclein autoantibodies | |
BRPI0506726B8 (pt) | anticorpo monoclonal específico para m-csf e usos deste | |
MX355181B (es) | Anticuerpos humanos contra el factor tisular. | |
WO2007109236A8 (en) | Microrna fingerprints during human megakaryocytopoiesis | |
EA200802213A1 (ru) | Способы лечения заболеваний крови | |
DK1893196T3 (da) | Diarylhydantoin-forbindelse | |
DOP2009000269A (es) | Anticuerpos humanizados contra el globulomero ab(20-42) y sus usos | |
DK1629011T3 (da) | Humane anti-humane-DC3-bindingsmolekyler | |
MX2010005022A (es) | Anticuerpos que unen celulas dendriticas y epiteliales 205 (dec-205) humanas. | |
BRPI0613382A8 (pt) | anticorpos isolados, anticorpo monoclonal, célula de hibridoma, método de identificação, método de inibição do crescimento de uma célula, método de tratamento terapêutico, método de determinação da presença de uma proteína, métodos de diagnósticos da presença de tumor | |
MX2009008430A (es) | Anticuerpos anti-robo4 y sus usos. | |
SG166788A1 (en) | Use of b cell expansion agents in generating antibodies | |
AU2006226733A8 (en) | Antibodies against CD38 for treatment of multiple myeloma | |
BR122018069446B8 (pt) | método in vitro para detectar a presença de um célula de câncer em um indivíduo | |
WO2007016548A3 (en) | Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer | |
MX2019005150A (es) | Inhibidores de la tirosina-cinasa de bruton. | |
MX2008012754A (es) | Composiciones de anticuerpos y metodos para tratamiento de enfermedad neoplastica. | |
MX2010000537A (es) | Anticuerpos monoclonales contra glipicano-3. | |
EP1855719A4 (en) | NEUTRALIZING MONOCLONAL ANTIBODIES TO CORONAVIRES IN CONNECTION WITH HEAVY ACUTE RESPIRATORY SYNDROME | |
SG171599A1 (en) | Blood group antigens of different types for diagnostic and therapeutic applications | |
NZ579478A (en) | Epha3 antibodies for the treatment of solid tumors | |
DE602006012995D1 (de) | Brustkrebsdiagnoseverfahren | |
EP2722400A3 (en) | Methods of using biomarkers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 7A, 8A, 9A E 10A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2513 DE 06-03-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B350 | Update of information on the portal [chapter 15.35 patent gazette] |